- Home
- MPLT vs ACP Comparison
MPLT vs ACP Comparison
Compare MPLT & ACP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MPLT | ACP |
|---|---|---|
| Founded | 2018 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 822.2M | 675.0M |
| IPO Year | 2025 | N/A |
Fundamental Metrics
Financial Performance| Metric | MPLT | ACP |
|---|---|---|
| Price | $17.02 | $5.51 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $31.00 | N/A |
| AVG Volume (30 Days) | ★ 361.8K | 337.9K |
| Earning Date | 02-28-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 17.79% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $12.24 | $5.55 |
| 52 Week High | $21.55 | $7.17 |
Technical Indicators
Market Signals| Indicator | MPLT | ACP |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 58.18 |
| Support Level | N/A | $5.35 |
| Resistance Level | N/A | $5.52 |
| Average True Range (ATR) | 0.00 | 0.04 |
| MACD | 0.00 | 0.01 |
| Stochastic Oscillator | 0.00 | 91.18 |
Price Performance
Historical ComparisonAbout MPLT MapLight Therapeutics Inc.
MapLight Therapeutics Inc is a biopharmaceutical company. The company is focused on improving the lives of patients suffering from debilitating central nervous system, or CNS, disorders. The company is engaged in psychiatry and neuroscience research to address the lack of circuit-specific pharmacotherapies available for patients. The product candidates of the company include ML-007C-MA, ML-004, ML-021, ML-009, and other pipeline products.
About ACP abrdn Income Credit Strategies Fund
abrdn Income Credit Strategies Fund is a diversified, closed-end management investment company. Its investment objective is to seek a high level of current income with a secondary objective of capital appreciation. It predominantly invests in debt and loan instruments of issues that operate in a variety of industries and geographic regions.